RYTM - Rhythm Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RYTM is currently covered by 12 analysts with an average price target of $143.68. This is a potential upside of $50.85 (54.78%) from yesterday's end of day stock price of $92.83.

Rhythm Pharmaceuticals's activity chart (see below) currently has 231 price targets and 222 ratings on display. The stock rating distribution of RYTM is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 71.27% with an average time for these price targets to be met of 225.68 days.

Highest price target for RYTM is $160, Lowest price target is $105, average price target is $143.68.

Most recent stock forecast was given by PRIYANKA GROVER from JPMORGAN on 07-Aug-2026. First documented stock forecast 30-Oct-2017.

Best performing analysts who are covering RYTM - Rhythm Pharmaceuticals:

Seamus Fernandez Whitney Ijem Paul Matteis Dae Gon Ha Jonathan Wolleben Dennis Ding

Currently out of the existing stock ratings of RYTM, 46 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 27-Jul-2026

$146

$53.17 (57.28%)

$145

1 months 28 days ago
(07-Aug-2026)

0/2 (0%)

$30.37 (26.26%)

Buy Since 19-Feb-2026

$155

$62.17 (66.97%)

$141

2 months ago
(05-Aug-2026)

0/5 (0%)

$44.29 (40.01%)

Buy Since 17-Mar-2026

$143

$50.17 (54.05%)

$142

2 months ago
(05-Aug-2026)

0/4 (0%)

$32.29 (29.17%)

Buy Since 17-Sep-2024

$160

$67.17 (72.36%)

$155

2 months ago
(05-Aug-2026)

7/15 (46.67%)

$49.29 (44.52%)

91

Buy Since 02-Mar-2023

$151

$58.17 (62.66%)

$151

3 months 5 days ago
(30-Jun-2026)

11/16 (68.75%)

$39.97 (36.00%)

281

Show more analysts

Please expand the browser size to see the chart

What is RYTM (Rhythm Pharmaceuticals) average time for price targets to be met?

On average it took 226 days for the stock forecasts to be reached, with an average price target met ratio of 71.27%.

Which analyst most recently updated their price target on RYTM (Rhythm Pharmaceuticals)?

Priyanka Grover

Which analyst has the most public recommendations on RYTM (Rhythm Pharmaceuticals)?

Priyanka Grover works at JPMORGAN and has 3 price targets and 2 ratings on RYTM

Which analyst is the currently most bullish on RYTM (Rhythm Pharmaceuticals)?

Jonathan Wolleben with the highest potential upside of $67.17

Which analyst is the currently most reserved on RYTM (Rhythm Pharmaceuticals)?

Graig Suvannavejh with the lowest potential downside of -$86.83
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?